Literature DB >> 24611756

Dopamine denervation of the prefrontal cortex increases expression of the astrocytic glutamate transporter GLT-1.

Peter J Vollbrecht1, Linda D Simmler, Randy D Blakely, Ariel Y Deutch.   

Abstract

Both dopamine and glutamate are critically involved in cognitive processes such as working memory. Astrocytes, which express dopamine receptors, are essential elements in the termination of glutamatergic signaling: the astrocytic glutamate transporter GLT-1 is responsible for > 90% of cortical glutamate uptake. The effect of dopamine depletion on glutamate transporters in the prefrontal cortex (PFC) remains unknown. In an effort to determine if astrocytes are a locus of cortical dopamine-glutamate interactions, we examined the effects of chronic dopamine denervation on PFC protein and mRNA levels of glutamate transporters. PFC dopamine denervation elicited a marked increase in GLT-1 protein levels, but had no effect on levels of other glutamate transporters; high-affinity glutamate transport was positively correlated with the extent of dopamine depletion. GLT-1 gene expression was not altered. Our data suggest that dopamine depletion may lead to post-translational modifications that result in increased expression and activity of GLT-1 in PFC astrocytes. The glutamate transporter GLT-1 is expressed by astrocytes, which also express dopamine receptors. Regulation of prefrontal cortical (PFC) GLT-1 potentially offers a novel treatment approach to the cognitive deficits of schizophrenia. Partial PFC dopamine deafferentation increased membrane expression of GLT-1 protein and glutamate uptake, but did not alter levels of the other two neocortical glutamate transporters, GLAST and EAAC1.
© 2014 International Society for Neurochemistry.

Entities:  

Keywords:  EAAT2; GLAST; astrocyte; dopamine; prefrontal cortex; schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 24611756      PMCID: PMC4065617          DOI: 10.1111/jnc.12697

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

1.  EAAC1, a high-affinity glutamate tranporter, is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex.

Authors:  F Conti; S DeBiasi; A Minelli; J D Rothstein; M Melone
Journal:  Cereb Cortex       Date:  1998-03       Impact factor: 5.357

2.  Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems.

Authors:  D J Healy; J H Meador-Woodruff
Journal:  Brain Res       Date:  1996-02-05       Impact factor: 3.252

3.  Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.

Authors:  K Tanaka; K Watase; T Manabe; K Yamada; M Watanabe; K Takahashi; H Iwama; T Nishikawa; N Ichihara; T Kikuchi; S Okuyama; N Kawashima; S Hori; M Takimoto; K Wada
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

4.  Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia.

Authors:  T Ohnuma; S J Augood; H Arai; P J McKenna; P C Emson
Journal:  Brain Res Mol Brain Res       Date:  1998-05

5.  Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations.

Authors:  K P Lehre; L M Levy; O P Ottersen; J Storm-Mathisen; N C Danbolt
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

6.  Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.

Authors:  S R Sesack; V A Hawrylak; C Matus; M A Guido; A I Levey
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

7.  Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats.

Authors:  D A Daly; B Moghaddam
Journal:  Neurosci Lett       Date:  1993-04-02       Impact factor: 3.046

8.  Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies.

Authors:  A Bal; T Bachelot; M Savasta; M Manier; J M Verna; A L Benabid; C Feuerstein
Journal:  Brain Res Mol Brain Res       Date:  1994-05

9.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

Authors:  J H Krystal; L P Karper; J P Seibyl; G K Freeman; R Delaney; J D Bremner; G R Heninger; M B Bowers; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1994-03

10.  6-Hydroxydopamine lesions of the medial prefrontal cortex of rats do not affect dopamine metabolism in the basal ganglia at short and long postsurgical intervals.

Authors:  M Bubser
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

View more
  5 in total

1.  The role of glutamate signaling in incentive salience: second-by-second glutamate recordings in awake Sprague-Dawley rats.

Authors:  Seth R Batten; Francois Pomerleau; Jorge Quintero; Greg A Gerhardt; Joshua S Beckmann
Journal:  J Neurochem       Date:  2018-05-15       Impact factor: 5.372

Review 2.  Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets.

Authors:  Kjell Fuxe; Luigi F Agnati; Manuela Marcoli; Dasiel O Borroto-Escuela
Journal:  Neurochem Res       Date:  2015-04-17       Impact factor: 3.996

3.  Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.

Authors:  D M Bortz; H-Q Wu; R Schwarcz; J P Bruno
Journal:  Neuropharmacology       Date:  2017-04-15       Impact factor: 5.250

4.  Astroglia in the Vulnerability and Maintenance of Alcohol Use Disorders.

Authors:  José Javier Miguel-Hidalgo
Journal:  Adv Neurobiol       Date:  2021

Review 5.  Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease.

Authors:  Yunlong Zhang; Feng Tan; Pingyi Xu; Shaogang Qu
Journal:  Neural Plast       Date:  2016-02-14       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.